Recruiting Ovarian Cancer Studies in Seoul
About Ovarian Cancer Clinical Trials in Seoul
Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.
There are currently 1 ovarian cancer clinical trials recruiting participants in Seoul, SEOUL. These studies are seeking a combined 220 participants. Research is being sponsored by Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ovarian Cancer Clinical Trials in Seoul — FAQ
Are there ovarian cancer clinical trials in Seoul?
Yes, there are 1 ovarian cancer clinical trials currently recruiting in Seoul, SEOUL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seoul?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seoul research site will contact you about next steps.
Are clinical trials in Seoul free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seoul studies also compensate for your time and travel.
What ovarian cancer treatments are being tested?
The 1 active trials in Seoul are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.
Data updated March 2, 2026 from ClinicalTrials.gov